Previous work also implicated the MAPK pathway as a potential disease-modifying route in epilepsy (Parrish et al., 2018), while transcription factors, such as Creb, are increasingly considered as targets for therapy in seizure disorders (Sun et al., 2022). This evidence concerns the gene CREB1 and epilepsy.